2017 Q1 Form 10-K Financial Statement

#000101008617000005 Filed on March 07, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2015 Q4 2015 Q3
Revenue $5.202M $4.200M $1.300M
YoY Change 300.15% 425.0% 18.18%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.870M $2.568M $2.321M
YoY Change 8.06% 5.98% -46.2%
% of Gross Profit
Research & Development $6.360M $4.934M $2.427M
YoY Change 150.79% 69.96% -11.49%
% of Gross Profit
Depreciation & Amortization $36.00K $50.00K $52.29K
YoY Change -19.01% -37.5% -40.06%
% of Gross Profit
Operating Expenses $9.471M $7.502M $4.956M
YoY Change 13.71% 40.86% -97.29%
Operating Profit -$4.269M -$17.95M -$3.629M
YoY Change -39.52% 2.27% -98.0%
Interest Expense $3.609M $0.00 $0.00
YoY Change -100.0% -100.0%
% of Operating Profit
Other Income/Expense, Net $4.419K $0.00 $12.48K
YoY Change -60.93% 249560.0%
Pretax Income $8.500M -$19.90M $5.600M
YoY Change -18.27% 2.05% -103.07%
Income Tax $115.1K $200.0K $65.91K
% Of Pretax Income 1.35% 1.18%
Net Earnings -$8.615M -$20.09M -$5.631M
YoY Change -17.55% 5.45% -97.65%
Net Earnings / Revenue -165.61% -478.43% -433.15%
Basic Earnings Per Share
Diluted Earnings Per Share -$109.1K -$371.5K -$103.9K
COMMON SHARES
Basic Shares Outstanding 78.78M shares 54.11M shares 53.87M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q1 2015 Q4 2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $30.10M $112.7M $129.3M
YoY Change -71.09% 13.04% 23.5%
Cash & Equivalents $30.10M $112.7M $129.3M
Short-Term Investments
Other Short-Term Assets $11.00M $600.0K $8.200M
YoY Change 1733.33% -94.34% 1071.43%
Inventory $19.12M $12.45M $1.092M
Prepaid Expenses
Receivables $4.879M $3.677M $979.2K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $65.17M $129.5M $139.5M
YoY Change -49.27% 4.28% 12.42%
LONG-TERM ASSETS
Property, Plant & Equipment $263.3K $449.8K $457.5K
YoY Change -36.38% -45.93% -49.91%
Goodwill $898.3K $898.3K $898.3K
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $642.1K $1.990M $1.990M
YoY Change -67.73% 0.0% -0.1%
Total Long-Term Assets $95.65M $56.27M $57.65M
YoY Change 69.78% 53.84% 41.96%
TOTAL ASSETS
Total Short-Term Assets $65.17M $129.5M $139.5M
Total Long-Term Assets $95.65M $56.27M $57.65M
Total Assets $160.8M $185.7M $197.2M
YoY Change -12.97% 15.56% 19.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.259M $3.944M $3.175M
YoY Change -73.4% 16.55% 366.25%
Accrued Expenses $2.948M $3.389M $3.063M
YoY Change -41.56% 62.45% 59.08%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $12.56M $7.333M $6.238M
YoY Change -7.22% -1.7% 35.87%
LONG-TERM LIABILITIES
Long-Term Debt $67.70M $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $376.4M $462.6M $448.1M
YoY Change -19.18% 15.79% 15.67%
Total Long-Term Liabilities $444.1M $462.6M $448.1M
YoY Change -4.64% 89603.24%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.56M $7.333M $6.238M
Total Long-Term Liabilities $444.1M $462.6M $448.1M
Total Liabilities $457.0M $470.2M $461.8M
YoY Change -4.7% 15.45% 17.61%
SHAREHOLDERS EQUITY
Retained Earnings -$509.8M -$461.4M -$441.3M
YoY Change 8.02% 9.35% 9.53%
Common Stock $213.6M $177.0M $176.7M
YoY Change 20.54% 0.87% 0.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$296.1M -$284.4M -$264.7M
YoY Change
Total Liabilities & Shareholders Equity $160.8M $185.7M $197.2M
YoY Change -12.97% 15.56% 19.7%

Cashflow Statement

Concept 2017 Q1 2015 Q4 2015 Q3
OPERATING ACTIVITIES
Net Income -$8.615M -$20.09M -$5.631M
YoY Change -17.55% 5.45% -97.65%
Depreciation, Depletion And Amortization $36.00K $50.00K $52.29K
YoY Change -19.01% -37.5% -40.06%
Cash From Operating Activities -$933.0K -$16.52M $13.70M
YoY Change -89.2% 270.4% 35.38%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$50.00K -$60.00K
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 -$50.00K -$60.00K
YoY Change -100.0% -98.49%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$193.1K -10.00K 0.000
YoY Change -98.0% -100.0%
NET CHANGE
Cash From Operating Activities -$933.0K -16.52M 13.70M
Cash From Investing Activities $0.00 -50.00K -60.00K
Cash From Financing Activities -$193.1K -10.00K 0.000
Net Change In Cash -$1.126M -16.58M 13.64M
YoY Change -86.98% 234.27% 141.42%
FREE CASH FLOW
Cash From Operating Activities -$933.0K -$16.52M $13.70M
Capital Expenditures $0.00 -$50.00K -$60.00K
Free Cash Flow -$933.0K -$16.47M $13.76M
YoY Change -89.21% 269.28% 35.97%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014 siga Collateralfor Surety Bond
CollateralforSuretyBond
0 USD
CY2016 dei Amendment Flag
AmendmentFlag
false
CY2016 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2016 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2016 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016 dei Document Period End Date
DocumentPeriodEndDate
2016-12-31
CY2016 dei Document Type
DocumentType
10-K
CY2016 dei Entity Central Index Key
EntityCentralIndexKey
0001010086
CY2017Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
78780059 shares
CY2016 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2016 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2016Q2 dei Entity Public Float
EntityPublicFloat
54284296 USD
CY2016 dei Entity Registrant Name
EntityRegistrantName
SIGA TECHNOLOGIES INC
CY2016 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2016 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2016 dei Trading Symbol
TradingSymbol
SIGA
CY2016Q2 siga Amount To Be Paid On Effective Dateof Plan Of Reorganization
AmountToBePaidOnEffectiveDateofPlanOfReorganization
5000000 USD
CY2011Q2 siga Amountofoptiontobereceivedfrom Bard Aforapprovalforextensionof84mothexpiry
AmountofoptiontobereceivedfromBARDAforapprovalforextensionof84mothexpiry
50000000 USD
CY2014 siga Backstop Fee
BackstopFee
0 USD
CY2015 siga Backstop Fee
BackstopFee
0 USD
CY2016 siga Backstop Fee
BackstopFee
1764240 USD
CY2014 siga Change In Excess Tax Benefit Stock Based Compensation Financing Activities
ChangeInExcessTaxBenefitStockBasedCompensationFinancingActivities
0 USD
CY2015 siga Change In Excess Tax Benefit Stock Based Compensation Financing Activities
ChangeInExcessTaxBenefitStockBasedCompensationFinancingActivities
15531 USD
CY2016 siga Change In Excess Tax Benefit Stock Based Compensation Financing Activities
ChangeInExcessTaxBenefitStockBasedCompensationFinancingActivities
0 USD
CY2015 siga Collateralfor Surety Bond
CollateralforSuretyBond
0 USD
CY2016 siga Collateralfor Surety Bond
CollateralforSuretyBond
1212591 USD
CY2015Q4 siga Computer Equipment
ComputerEquipment
754502 USD
CY2016Q4 siga Computer Equipment
ComputerEquipment
770479 USD
CY2011Q2 siga Contract Value Option Fda Approval
ContractValueOptionFDAApproval
50000000 USD
CY2015Q4 siga Deferred Tax Liabilities Capitalized Contract Costs
DeferredTaxLiabilitiesCapitalizedContractCosts
18922571 USD
CY2016Q4 siga Deferred Tax Liabilities Capitalized Contract Costs
DeferredTaxLiabilitiesCapitalizedContractCosts
25854435 USD
CY2014 siga Effective Income Tax Rate Reconciliation Loss From Fair Value Of Common Warrants
EffectiveIncomeTaxRateReconciliationLossFromFairValueOfCommonWarrants
0.000
CY2015 siga Effective Income Tax Rate Reconciliation Loss From Fair Value Of Common Warrants
EffectiveIncomeTaxRateReconciliationLossFromFairValueOfCommonWarrants
0.000
CY2016 siga Effective Income Tax Rate Reconciliation Loss From Fair Value Of Common Warrants
EffectiveIncomeTaxRateReconciliationLossFromFairValueOfCommonWarrants
-0.008
CY2014 siga Effective Income Tax Rate Reconciliation Loss From Reorganization Costs
EffectiveIncomeTaxRateReconciliationLossFromReorganizationCosts
-0.004
CY2011Q2 siga Contract Value Detail Of Option Exercisable Development Activities
ContractValueDetailOfOptionExercisableDevelopmentActivities
58300000 USD
CY2011Q2 siga Contract Value Detail Of Option Exercisable Production Activities
ContractValueDetailOfOptionExercisableProductionActivities
14400000 USD
CY2011Q2 siga Contract Valueof Various Options
ContractValueofVariousOptions
122700000 USD
CY2011Q2 siga Holdbackamountpending Fd Aapproval
HoldbackamountpendingFDAapproval
102500000 USD
CY2016 siga Number Of Active Contracts
NumberOfActiveContracts
1 contract
CY2016 siga Number Of Active Grants
NumberOfActiveGrants
1 grant
CY2011Q2 siga Reducedholdbackamount
Reducedholdbackamount
41000000 USD
CY2015 siga Effective Income Tax Rate Reconciliation Loss From Reorganization Costs
EffectiveIncomeTaxRateReconciliationLossFromReorganizationCosts
-0.070
CY2016 siga Effective Income Tax Rate Reconciliation Loss From Reorganization Costs
EffectiveIncomeTaxRateReconciliationLossFromReorganizationCosts
-0.033
CY2014 siga Income Taxes Paid Refund
IncomeTaxesPaidRefund
728442 USD
CY2015 siga Income Taxes Paid Refund
IncomeTaxesPaidRefund
-420029 USD
CY2016 siga Income Taxes Paid Refund
IncomeTaxesPaidRefund
500975 USD
CY2014 siga Increase In Fair Value Of Warrants
IncreaseInFairValueOfWarrants
-313425 USD
CY2015 siga Increase In Fair Value Of Warrants
IncreaseInFairValueOfWarrants
0 USD
CY2016 siga Increase In Fair Value Of Warrants
IncreaseInFairValueOfWarrants
894785 USD
CY2014 siga Interest Paidon Pharm Athene Liability
InterestPaidonPharmAtheneLiability
0 USD
CY2015 siga Interest Paidon Pharm Athene Liability
InterestPaidonPharmAtheneLiability
0 USD
CY2016 siga Interest Paidon Pharm Athene Liability
InterestPaidonPharmAtheneLiability
11668900 USD
CY2014 siga Interest Paidon Term Loan From Restricted Cash
InterestPaidonTermLoanFromRestrictedCash
0 USD
CY2015 siga Interest Paidon Term Loan From Restricted Cash
InterestPaidonTermLoanFromRestrictedCash
0 USD
CY2016 siga Interest Paidon Term Loan From Restricted Cash
InterestPaidonTermLoanFromRestrictedCash
1222222 USD
CY2015 siga Inventory Write Downs
InventoryWriteDowns
60000 USD
CY2015Q4 siga Liabilitiessubjecttocompromiseaccountspayable
Liabilitiessubjecttocompromiseaccountspayable
834219 USD
CY2016Q4 siga Liabilitiessubjecttocompromiseaccountspayable
Liabilitiessubjecttocompromiseaccountspayable
0 USD
CY2015Q4 siga Liabilitiessubjecttocompromiselosscontingencylegalfees
Liabilitiessubjecttocompromiselosscontingencylegalfees
3200000 USD
CY2015Q4 siga Liabilitiessubjecttocompromiseotheraccruedexpense
Liabilitiessubjecttocompromiseotheraccruedexpense
737883 USD
CY2016Q4 siga Liabilitiessubjecttocompromiseotheraccruedexpense
Liabilitiessubjecttocompromiseotheraccruedexpense
0 USD
CY2014 siga Loss On Disposal Of Assets
LossOnDisposalOfAssets
0 USD
CY2015 siga Loss On Disposal Of Assets
LossOnDisposalOfAssets
-243707 USD
CY2016 siga Loss On Disposal Of Assets
LossOnDisposalOfAssets
0 USD
CY2016Q4 siga Numberof Coursestobe Deliveredby Company
NumberofCoursestobeDeliveredbyCompany
467000 course
CY2014 siga Patent Preparation Fees
PatentPreparationFees
987777 USD
CY2015Q1 siga Patent Preparation Fees
PatentPreparationFees
333000 USD
CY2015Q2 siga Patent Preparation Fees
PatentPreparationFees
236000 USD
CY2015Q3 siga Patent Preparation Fees
PatentPreparationFees
194000 USD
CY2015Q4 siga Patent Preparation Fees
PatentPreparationFees
246000 USD
CY2015 siga Patent Preparation Fees
PatentPreparationFees
1009053 USD
CY2016Q1 siga Patent Preparation Fees
PatentPreparationFees
0 USD
CY2016Q2 siga Patent Preparation Fees
PatentPreparationFees
0 USD
CY2016Q3 siga Patent Preparation Fees
PatentPreparationFees
0 USD
CY2016Q4 siga Patent Preparation Fees
PatentPreparationFees
0 USD
CY2016 siga Patent Preparation Fees
PatentPreparationFees
909376 USD
CY2016Q3 siga Payment To Extend Days To Satisfy Claim
PaymentToExtendDaysToSatisfyClaim
100000000 USD
CY2016Q4 siga Payment To Extend Days To Satisfy Claim
PaymentToExtendDaysToSatisfyClaim
10000000 USD
CY2016Q4 siga Payment To Extend Days To Satisfy Claim
PaymentToExtendDaysToSatisfyClaim
100000000 USD
CY2015Q4 siga Payment To Post Collateral For Surety Bond
PaymentToPostCollateralForSuretyBond
1300000 USD
CY2016Q4 siga Payment To Post Collateral For Surety Bond
PaymentToPostCollateralForSuretyBond
1200000 USD
CY2014 siga Paymentof Interest Expense
PaymentofInterestExpense
0 USD
CY2015 siga Paymentof Interest Expense
PaymentofInterestExpense
0 USD
CY2016 siga Paymentof Interest Expense
PaymentofInterestExpense
-1222222 USD
CY2016Q4 siga Paymenttoextend120daystosatisfypharm Atheneclaim
Paymenttoextend120daystosatisfypharmAtheneclaim
20000000 USD
CY2014 siga Proceeds From Issuance Of Warrants And Options
ProceedsFromIssuanceOfWarrantsAndOptions
102035 USD
CY2015 siga Proceeds From Issuance Of Warrants And Options
ProceedsFromIssuanceOfWarrantsAndOptions
12200 USD
CY2016 siga Proceeds From Issuance Of Warrants And Options
ProceedsFromIssuanceOfWarrantsAndOptions
0 USD
CY2014 siga Proceedsfrom Equity Rights Offering Net
ProceedsfromEquityRightsOfferingNet
0 USD
CY2015 siga Proceedsfrom Equity Rights Offering Net
ProceedsfromEquityRightsOfferingNet
0 USD
CY2016 siga Proceedsfrom Equity Rights Offering Net
ProceedsfromEquityRightsOfferingNet
34596468 USD
CY2015Q4 siga Receivables Percentage
ReceivablesPercentage
1
CY2016Q4 siga Receivables Percentage
ReceivablesPercentage
1
CY2014 siga Reclass Of Common Stock Warrant Liability To Additional Paid In Capital Upon Exercise
ReclassOfCommonStockWarrantLiabilityToAdditionalPaidInCapitalUponExercise
751370 USD
CY2015 siga Reclass Of Common Stock Warrant Liability To Additional Paid In Capital Upon Exercise
ReclassOfCommonStockWarrantLiabilityToAdditionalPaidInCapitalUponExercise
0 USD
CY2016 siga Reclass Of Common Stock Warrant Liability To Additional Paid In Capital Upon Exercise
ReclassOfCommonStockWarrantLiabilityToAdditionalPaidInCapitalUponExercise
0 USD
CY2016 siga Reducedholdbackamount
Reducedholdbackamount
41000000 USD
CY2014 siga Rent Expense Facilities Lease
RentExpenseFacilitiesLease
1600000 USD
CY2015 siga Rent Expense Facilities Lease
RentExpenseFacilitiesLease
1400000 USD
CY2016 siga Rent Expense Facilities Lease
RentExpenseFacilitiesLease
1200000 USD
CY2015Q2 siga Rent Reduction
RentReduction
35000 USD
CY2015 siga Reorganization Payments
ReorganizationPayments
6700000 USD
CY2016 siga Reorganization Payments
ReorganizationPayments
4600000 USD
CY2015 siga Reorganization Professional Fees
ReorganizationProfessionalFees
2027827 USD
CY2016 siga Reorganization Professional Fees
ReorganizationProfessionalFees
1732521 USD
CY2015 siga Reorganization Trusteefees
ReorganizationTrusteefees
59000 USD
CY2016 siga Reorganization Trusteefees
ReorganizationTrusteefees
33000 USD
CY2014 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
3139835 USD
CY2015Q1 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
1192000 USD
CY2015Q2 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
1468000 USD
CY2015Q3 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
1327000 USD
CY2015Q4 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
4189000 USD
CY2015 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
8175878 USD
CY2016Q1 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
1000 USD
CY2016Q2 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
2000 USD
CY2016Q3 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
5000 USD
CY2016Q4 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
7000 USD
CY2016 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
14987628 USD
CY2016 siga Researchand Development Revenue Longterm Contract
ResearchandDevelopmentRevenueLongtermContract
13200000 USD
CY2014 siga Revenue Percentage
RevenuePercentage
1
CY2015 siga Revenue Percentage
RevenuePercentage
1
CY2016 siga Revenue Percentage
RevenuePercentage
1.00
CY2015Q4 siga Share Based Compensation Arrangement By Share Based Payment Award Options Performance Based Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPerformanceBasedNumber
200000 shares
CY2014 siga Stock Issuance Fees Expense
StockIssuanceFeesExpense
0 USD
CY2015 siga Stock Issuance Fees Expense
StockIssuanceFeesExpense
0 USD
CY2016 siga Stock Issuance Fees Expense
StockIssuanceFeesExpense
1764240 USD
CY2016 siga Stock Issued During Period Value Backstop Agreement
StockIssuedDuringPeriodValueBackstopAgreement
1764240 USD
CY2016 siga Stock Issued During Period Value Rights Offering
StockIssuedDuringPeriodValueRightsOffering
34596469 USD
CY2016Q4 siga Suretybond
Suretybond
2700000 USD
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3944476 USD
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2517072 USD
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3676730 USD
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3154370 USD
CY2015Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
580801 USD
CY2016Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2357194 USD
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3388608 USD
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4584752 USD
CY2015Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
597721 USD
CY2016Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
481641 USD
CY2015Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
227863 USD
CY2016Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
262664 USD
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3299417 USD
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3468266 USD
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
177008371 USD
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
213714154 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2299098 USD
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1528582 USD
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
775541 USD
CY2016 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
1600000 USD
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2400000 USD
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1600000 USD
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
775541 USD
CY2015Q4 us-gaap Assets
Assets
185732936 USD
CY2016Q4 us-gaap Assets
Assets
160981977 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
129458829 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
69159474 USD
CY2016Q4 us-gaap Bankruptcy Claims Amount Paid To Settle Claims
BankruptcyClaimsAmountPaidToSettleClaims
800000 USD
CY2016Q4 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
620000000 shares
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
91309754 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
99713929 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
112711028 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28701824 USD
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
8404175 USD
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
12997099 USD
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-84009204 USD
CY2016Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.29
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54114296 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
78692612 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
54114296 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
78692612 shares
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
5411 USD
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
7869 USD
CY2014 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-10428 USD
CY2015 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
439934 USD
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-5093 USD
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-40803 USD
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
440880 USD
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-6539 USD
CY2014 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-30375 USD
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-1446 USD
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
946 USD
CY2015 us-gaap Debtor Reorganization Items Legal And Advisory Professional Fees
DebtorReorganizationItemsLegalAndAdvisoryProfessionalFees
5719052 USD
CY2016 us-gaap Debtor Reorganization Items Legal And Advisory Professional Fees
DebtorReorganizationItemsLegalAndAdvisoryProfessionalFees
1951381 USD
CY2015 us-gaap Debtor Reorganization Items Other Expense Income
DebtorReorganizationItemsOtherExpenseIncome
5672 USD
CY2016 us-gaap Debtor Reorganization Items Other Expense Income
DebtorReorganizationItemsOtherExpenseIncome
0 USD
CY2015Q4 us-gaap Deferred Costs
DeferredCosts
52936428 USD
CY2016Q4 us-gaap Deferred Costs
DeferredCosts
72649277 USD
CY2014 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
53198632 USD
CY2015 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
19006 USD
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
21252 USD
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
53569071 USD
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
21103 USD
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
20423 USD
CY2015Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
255258371 USD
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
367483905 USD
CY2014 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
370439 USD
CY2015 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
2097 USD
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-829 USD
CY2015Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
59892477 USD
CY2016Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
102520433 USD
CY2015Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
887906 USD
CY2016Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
665531 USD
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
162677117 USD
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
182303388 USD
CY2015Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
19154448 USD
CY2016Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
26838215 USD
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
22701028 USD
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
72726440 USD
CY2015Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
0 USD
CY2016Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1337941 USD
CY2015Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
662011 USD
CY2016Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
667008 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax
DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
2034283 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax
DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
2000000 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax
DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
2029190 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
1130413 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
669602 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1947019 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1687243 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies
73421980 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies
0 USD
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
143522669 USD
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
155465173 USD
CY2015Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
265643 USD
CY2016Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
286066 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
267598 USD
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.18
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.17
CY2016Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.15
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.69
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.253
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.012
CY2016Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
287729 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
265643 USD
CY2016Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
286066 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
229922 USD
CY2016Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
982117 USD
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
351561 USD
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
247357 USD
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
174275 USD
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-4.97
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
CY2015Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.38
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.73
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.19
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.597
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.278
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.301
CY2014 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.000
CY2015 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.014
CY2016 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.002
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.002
CY2015 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.000
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.006
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
894785000 USD
CY2016Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
6727409000 USD
CY2016Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
5832624000 USD
CY2015Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
452696 USD
CY2016Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
455220 USD
CY2014 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
345658 USD
CY2015 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2016 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2015Q4 us-gaap Goodwill
Goodwill
898334 USD
CY2016Q4 us-gaap Goodwill
Goodwill
898334 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-211934870 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-38989341 USD
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
13762876 USD
CY2014 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-43186 USD
CY2015 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
0 USD
CY2016 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-80928 USD
CY2014 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-42280 USD
CY2015 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-73107 USD
CY2016 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-84228 USD
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-39684076 USD
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
53528268 USD
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
461983 USD
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13884 USD
CY2014 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4436468 USD
CY2015 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1862779 USD
CY2016 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-177342 USD
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-490391 USD
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3185098 USD
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-522360 USD
CY2014 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
10277672 USD
CY2015 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
20075554 USD
CY2016 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
19712849 USD
CY2014 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-162140390 USD
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
255176572 USD
CY2016 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
112225534 USD
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1470872 USD
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-6597389 USD
CY2014 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
236134 USD
CY2015 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-229266 USD
CY2016 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
330443 USD
CY2014 us-gaap Interest Expense
InterestExpense
455810 USD
CY2015 us-gaap Interest Expense
InterestExpense
266726 USD
CY2016 us-gaap Interest Expense
InterestExpense
2395517 USD
CY2015Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
0 USD
CY2016Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
7293880 USD
CY2015Q4 us-gaap Inventory Net
InventoryNet
12447088 USD
CY2016Q4 us-gaap Inventory Net
InventoryNet
26209964 USD
CY2015Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
12447088 USD
CY2016Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
18916084 USD
CY2015Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
2542044 USD
CY2016Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
2542044 USD
CY2015Q4 us-gaap Liabilities
Liabilities
470161486 USD
CY2016Q4 us-gaap Liabilities
Liabilities
448400246 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
185732936 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
160981977 USD
CY2014 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
0 USD
CY2015 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
0 USD
CY2016 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
5832624 USD
CY2016Q2 us-gaap Liabilities Subject To Compromise Expense Income Items
LiabilitiesSubjectToCompromiseExpenseIncomeItems
684000 USD
CY2014 us-gaap Liabilities Subject To Compromise Period Increase Decrease
LiabilitiesSubjectToCompromisePeriodIncreaseDecrease
399039967 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7333084 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
13829233 USD
CY2015Q4 us-gaap Liabilities Subject To Compromise
LiabilitiesSubjectToCompromise
206972170 USD
CY2016Q4 us-gaap Liabilities Subject To Compromise
LiabilitiesSubjectToCompromise
0 USD
CY2015 us-gaap Liabilities Subject To Compromise Period Increase Decrease
LiabilitiesSubjectToCompromisePeriodIncreaseDecrease
-192067797 USD
CY2016 us-gaap Liabilities Subject To Compromise Period Increase Decrease
LiabilitiesSubjectToCompromisePeriodIncreaseDecrease
-160072170 USD
CY2014 us-gaap Litigation Settlement Interest
LitigationSettlementInterest
0 USD
CY2015 us-gaap Litigation Settlement Interest
LitigationSettlementInterest
0 USD
CY2016Q1 us-gaap Litigation Settlement Interest
LitigationSettlementInterest
3000 USD
CY2016Q2 us-gaap Litigation Settlement Interest
LitigationSettlementInterest
4000 USD
CY2016Q3 us-gaap Litigation Settlement Interest
LitigationSettlementInterest
4000 USD
CY2016Q4 us-gaap Litigation Settlement Interest
LitigationSettlementInterest
1000 USD
CY2016 us-gaap Litigation Settlement Interest
LitigationSettlementInterest
11668900 USD
CY2015Q4 us-gaap Loans Payable
LoansPayable
0 USD
CY2016Q4 us-gaap Loans Payable
LoansPayable
66553053 USD
CY2015Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
205400068 USD
CY2016Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0 USD
CY2014 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
188465065 USD
CY2015Q1 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
0 USD
CY2015Q2 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
0 USD
CY2015Q3 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
14000 USD
CY2015Q4 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
14393000 USD
CY2015 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
14407494 USD
CY2016 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
0 USD
CY2014 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2313906 USD
CY2015 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2003331 USD
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
30392913 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3458439 USD
CY2015 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3891047 USD
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1188664 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
14176520 USD
CY2015 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
11109383 USD
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-115590781 USD
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-265463138 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-7153000 USD
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-6573000 USD
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-5631000 USD
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
-20094000 USD
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-39451324 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-10000 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-10000 USD
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-9000 USD
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
-10000 USD
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-39697960 USD
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1065 USD
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
42202 USD
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
102324 USD
CY2014 us-gaap Notes Reduction
NotesReduction
0 USD
CY2015 us-gaap Notes Reduction
NotesReduction
0 USD
CY2016 us-gaap Notes Reduction
NotesReduction
46900000 USD
CY2014 us-gaap Operating Expenses
OperatingExpenses
212806849 USD
CY2015 us-gaap Operating Expenses
OperatingExpenses
39129144 USD
CY2016 us-gaap Operating Expenses
OperatingExpenses
46002584 USD
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-209667014 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5040000 USD
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4332000 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3629000 USD
CY2015Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-17952000 USD
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-30953266 USD
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7000 USD
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-9000 USD
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-8000 USD
CY2016Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-7000 USD
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-31014956 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
3261833 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1242797 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
512788 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
766476 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
739772 USD
CY2016Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
204900000 USD
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1982223 USD
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1483253 USD
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1989520 USD
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
642083 USD
CY2015Q4 us-gaap Other Liabilities
OtherLiabilities
332218 USD
CY2016Q4 us-gaap Other Liabilities
OtherLiabilities
247989 USD
CY2014 us-gaap Other Noncash Expense
OtherNoncashExpense
31175 USD
CY2015 us-gaap Other Noncash Expense
OtherNoncashExpense
10052 USD
CY2016 us-gaap Other Noncash Expense
OtherNoncashExpense
566779 USD
CY2016Q4 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
217000000 USD
CY2014 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
4000000 USD
CY2015 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-4000000 USD
CY2016 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 USD
CY2014 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2015 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2016 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
3775546 USD
CY2014 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
415940 USD
CY2015 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 USD
CY2016 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
428009 USD
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28046 USD
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
108953 USD
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
23927 USD
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
623983 USD
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
954426 USD
CY2014 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
569607 USD
CY2015 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 USD
CY2016 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 USD
CY2014 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
102035 USD
CY2015 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
12200 USD
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3749242 USD
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3767743 USD
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
449825 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
299477 USD
CY2014 us-gaap Reorganization Items
ReorganizationItems
2126536 USD
CY2015 us-gaap Reorganization Items
ReorganizationItems
7811551 USD
CY2016 us-gaap Reorganization Items
ReorganizationItems
3716902 USD
CY2014 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2000001 USD
CY2015 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2000000 USD
CY2016 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10707354 USD
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2811000 USD
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2959000 USD
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2427000 USD
CY2015Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4934000 USD
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13130529 USD
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3000 USD
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3000 USD
CY2016Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6000 USD
CY2016Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8000 USD
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19710673 USD
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
27500000 USD
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
0 USD
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
10100000 USD
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
10138890 USD
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
0 USD
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
17333332 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-461442332 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-501140292 USD
CY2014 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12646653 USD
CY2015Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3088000 USD
CY2015Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2605000 USD
CY2015Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2321000 USD
CY2015Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2568000 USD
CY2015 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10582068 USD
CY2016Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3000 USD
CY2016Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4000 USD
CY2016Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3000 USD
CY2016Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4000 USD
CY2016 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13713635 USD
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
2435462 USD
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
1574038 USD
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
775541 USD
CY2010Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
2000000 shares
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
4500000 shares
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
16975468 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
-246502477 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
-284428550 USD
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-287418269 USD
CY2015Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2016 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
11900000 USD
CY2015Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
0 USD
CY2016Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
6727409 USD
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
53419686 shares
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
53777687 shares
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
57188503 shares
CY2016 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Credit Risk</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has cash in bank accounts that exceed the Federal Deposit Insurance Corporation insured limits. The Company has not experienced any losses on its cash accounts and no allowance has been provided for potential credit losses because management believes that any such losses would be minimal, if any. </font></div></div>
CY2016 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consolidated financial statements and related disclosures are prepared in conformity with accounting principles generally accepted in the United States of America. Management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and revenue and expenses during the period reported. The most significant estimates include the variables used in the calculation of fair value of stock-based awards including options and warrants granted or issued by the Company; reported amounts of revenue; calculation of contingencies; and the realization of deferred tax assets. Estimates and assumptions are reviewed periodically and the effects of revisions are reflected in the financial statements in the period they are determined to be necessary. Actual results could differ from these estimates.</font></div></div>

Files In Submission

Name View Source Status
0001010086-17-000005-index-headers.html Edgar Link pending
0001010086-17-000005-index.html Edgar Link pending
0001010086-17-000005.txt Edgar Link pending
0001010086-17-000005-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
siga-20161231.xml Edgar Link completed
siga-20161231.xsd Edgar Link pending
siga-20161231x10k.htm Edgar Link pending
siga-20161231_cal.xml Edgar Link unprocessable
siga-20161231_def.xml Edgar Link unprocessable
siga-20161231_lab.xml Edgar Link unprocessable
siga-20161231_pre.xml Edgar Link unprocessable
siga-201612_chartx28023a01.jpg Edgar Link pending
siga-exhibit3112016ye.htm Edgar Link pending
siga-exhibit3122016ye.htm Edgar Link pending
siga-exhibit3212016ye.htm Edgar Link pending
siga-exhibit3222016ye.htm Edgar Link pending